Skip to main content
OpenTrials

Clinical trial condition

Neuroblastoma Recurrent

Explore clinical trials studying Neuroblastoma Recurrent. Study availability and eligibility vary by location and protocol.

9 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Neuroblastoma Recurrent trial results

Recruiting

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

NCT07085338

Conditions
Disease Attributes, Neuroblastoma Recurrent, Pathologic Processes, +2 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Motts Childrens Hospital Ann Arbor, Michigan, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
View Trial Details
Recruiting

177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

NCT04903899

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations
  • Rigshospitalet Copenhagen, Denmark
  • Vilnius University Hospital Vilnius, Vilnius County, Lithuania
  • Princess Maxima Center for Pediatric Oncology Utrecht, Netherlands
  • Oslo University Hospital, Rikshospitalet Oslo, Norway
View Trial Details
Completed

Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma

NCT02139397

Conditions
Neuroblastoma Recurrent
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States
  • Helen DeVos Children's Hospital Grand Rapids, Michigan, United States
View Trial Details

Related conditions